Back to Results
First PageMeta Content
Eli Lilly and Company / Lipoplatin / Cisplatin / Gemcitabine / Non-small-cell lung carcinoma / Chemotherapy regimens / Creatinine / Chemistry / Alkylating antineoplastic agents / Lung cancer


PUBLIC PRESS RELEASE 15 AUGUST, 2012 Pres s Releas e Lipoplatin™ can be administered to
Add to Reading List

Document Date: 2012-09-05 08:39:36

Open Document

File Size: 734,87 KB

Share Result on Facebook

City

Athens / Palo Alto / /

Company

REGULON GROUP / /

Country

United States / Greece / /

Event

FDA Phase / /

IndustryTerm

biopharmaceutical / encapsulation technology / healthcare cost savings / liposomal encapsulation technology / treatment of non-small cell lung cancer / /

MedicalCondition

NSCLC renal insufficiency / GI tract cancers / cancers / tumor / breast cancers / cancer / tumors / NSCLC / collaborators bladder cancer / patients progressive disease / significant results tract cancers / renal insufficiency / non-small cell lung cancer / stable disease / passive tumor / numerous other including metastases / pancreatic cancer / /

MedicalTreatment

chemotherapy / renal dialysis / /

Person

George / /

Product

cisplatin / paclitaxel / fluorouracil / NSCLC / /

ProvinceOrState

California / /

Technology

Drug Delivery / chemotherapy / liposomal encapsulation technology / encapsulation technology / dialysis / /

SocialTag